| __timestamp | BioCryst Pharmaceuticals, Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 122000 | 94103000 |
| Thursday, January 1, 2015 | 1896000 | 146194000 |
| Friday, January 1, 2016 | 2699000 | 130000 |
| Sunday, January 1, 2017 | 1702000 | 7353000 |
| Monday, January 1, 2018 | 471000 | 34193000 |
| Tuesday, January 1, 2019 | 4101000 | 56586000 |
| Wednesday, January 1, 2020 | 1676000 | 63382000 |
| Friday, January 1, 2021 | 7264000 | 97049000 |
| Saturday, January 1, 2022 | 6594000 | 139989000 |
| Sunday, January 1, 2023 | 4661000 | 150343000 |
Igniting the spark of knowledge
In the competitive landscape of biotechnology, understanding cost structures is crucial. This chart compares the cost of revenue for Sarepta Therapeutics, Inc. and BioCryst Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Sarepta consistently outpaced BioCryst, with costs peaking at approximately $150 million in 2023, a staggering 1,230% increase from its 2016 low. In contrast, BioCryst's costs remained relatively stable, with a notable peak in 2021 at $7.3 million, reflecting a 5,857% increase from 2014. This disparity highlights Sarepta's aggressive growth strategy, likely driven by its focus on developing treatments for rare diseases. Meanwhile, BioCryst's steadier cost trajectory suggests a more conservative approach. These trends offer insights into each company's operational strategies and market positioning, providing a window into the financial dynamics of the biotech sector.
Cost of Revenue Trends: Sanofi vs BioCryst Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Bristol-Myers Squibb Company and Sarepta Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Zoetis Inc. vs Sarepta Therapeutics, Inc.
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs BioCryst Pharmaceuticals, Inc.
Cost of Revenue Trends: Dr. Reddy's Laboratories Limited vs Sarepta Therapeutics, Inc.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Halozyme Therapeutics, Inc.'s Expenses
Cost of Revenue: Key Insights for Sarepta Therapeutics, Inc. and ACADIA Pharmaceuticals Inc.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Wave Life Sciences Ltd.'s Expenses
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Evotec SE's Expenses
Comparing Cost of Revenue Efficiency: Lantheus Holdings, Inc. vs BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored